To inhibit Gal-1 in GBM, Woensel et al. prepared a highly concentrated suspension of small interfering RNA (siRNA)-loaded chitosan nanoparticles to deliver siRNA to the CNS via nasal drug delivery. Here, LGALS1 is linked to glioblastoma.